1. Bioorg Med Chem Lett. 2006 Sep 1;16(17):4450-7. doi:
10.1016/j.bmcl.2006.06.045.  Epub 2006 Jun 30.

Synthesis and structure-activity relationships of retro bis-aminopyrrolidine 
urea (rAPU) derived small-molecule antagonists of the melanin-concentrating 
hormone receptor-1 (MCH-R1). Part 1.

Rowbottom MW(1), Vickers TD, Dyck B, Grey J, Tamiya J, Zhang M, Kiankarimi M, Wu 
D, Dwight W, Wade WS, Schwarz D, Heise CE, Madan A, Fisher A, Petroski R, 
Goodfellow VS.

Author information:
(1)Department of Medicinal Chemistry, Neurocrine Biosciences Inc., San Diego, CA 
92130, USA. mrowbottom@neurocrine.com

The design, synthesis, and SAR of a series of retro bis-aminopyrrolidine ureas 
are described. Compounds from this series exhibited potent binding affinity and 
functional activity at MCH-R1, and good oral bioavailability in rat.

DOI: 10.1016/j.bmcl.2006.06.045
PMID: 16814542 [Indexed for MEDLINE]
